Korsen, Melanie
Pfeuffer, Steffen
Rolfes, Leoni
Meuth, Sven G.
Hartung, Hans-Peter http://orcid.org/0000-0002-0614-6989
Funding for this research was provided by:
Heinrich-Heine-Universität Düsseldorf
Article History
Received: 7 September 2021
Accepted: 30 December 2021
First Online: 9 January 2022
Declarations
:
: Melanie Korsen: received travel reimbursements from Merck Serono and Biogen; research support from Merck Serono and Novartis. Steffen Pfeuffer: received travel grants from Sanofi Genzyme and Merck Serono, lecturing honoraria from Sanofi Genzyme, Mylan Healthcare, and Biogen, and research support from Diamed, Merck Serono, and the German Multiple Sclerosis Society Northrhine-Westphalia. Leoni Rolfes: received travel reimbursements from Merck Serono and Sanofi Genzyme, research support from Diamed, Merck Serono and Novartis. Her research is funded by the Interdisciplinary Center for Clinical Studies (IZKF) Muenster. Sven G. Meuth: received honoraria for lecturing and travel expenses for attending meetings from Almirall, Amicus Therapeutics Germany, Bayer Health Care, Biogen, Celgene, Diamed, Genzyme, MedDay Pharmaceuticals, Merck Serono, Novartis, Novo Nordisk, ONO Pharma, Roche, Sanofi-Aventis, Chugai Pharma, QuintilesIMS, and Teva. His research is funded by the German Ministry for Education and Research (BMBF), Deutsche Forschungsgemeinschaft (DFG), Else Kröner Fresenius Foundation, German Academic Exchange Service, Hertie Foundation, Interdisciplinary Center for Clinical Studies (IZKF) Muenster, German Foundation Neurology, and by Almirall, Amicus Therapeutics Germany, Biogen, Diamed, Fresenius Medical Care, Genzyme, Merck Serono, Novartis, ONO Pharma, Roche, and Teva. Hans-Peter Hartung: received fees for consulting and serving on steering and data monitoring committees from Bayer Healthcare, Biogen, CSL Behring, Celgene Receptos, GeNeuro, MedDay, MedImmune, Merck, Novartis, Octapharma, Roche, Teva, TG Therapeutics, VielaBio Horizon Therapeutics.The submitting author hereby declares that he takes responsibility for conduction and analysis of the data and that he had full access to all study data. The submitting author furthermore declares that there are no competing interests concerning these data and that the authors have all rights to publish the data. The submitted manuscript does not contain data that have been published in any other journal. The authors have no related articles under submission.